Sirona Biochem Corp. logo

Sirona Biochem Corp. (ZSB)

Market Open
6 Aug, 20:00
XDUS XDUS
0. 06
0
0%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
0.06
Previous Close
Add Transaction
Day Range
0.06 0.06
Year Range
0.06 0.06
Want to track ZSB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ZSB trading today higher at €0.06, an increase of 0% from yesterday's close, completing a monthly increase of 0% or €0. Over the past 12 months, ZSB stock gained 0%.
ZSB is not paying dividends to its shareholders.
The last earnings report, released on Mar 09, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

ZSB Chart

Sirona Biochem Corp. (ZSB) FAQ

What is the stock price today?

The current price is €0.06.

On which exchange is it traded?

Sirona Biochem Corp. is listed on XDUS.

What is its stock symbol?

The ticker symbol is ZSB.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Sirona Biochem Corp. ever had a stock split?

No, there has never been a stock split.

Sirona Biochem Corp. Profile

Biotechnology Industry
Healthcare Sector
Howard J. Verrico CEO
XDUS Exchange
CA82967M1005 ISIN
CA Country
10 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Sirona Biochem Corp. is a pioneering entity in the cosmetic and pharmaceutical fields, focusing on the development and commercialization of innovative active ingredients. Based in Vancouver, Canada, and extending its operations to France, the company is dedicated to creating advanced solutions that span across cosmetic skin lightening, diabetes management, anti-aging treatments, and anti-viral therapies. Initially founded in 2006 as High Rider Capital Inc., it underwent a significant rebranding to Sirona Biochem Corp. in May 2009. Through strategic research collaboration agreements, notably with the International Centre for Genetic Engineering and Biotechnology (ICGEB), Sirona Biochem is at the forefront of developing antiviral compounds, showcasing its commitment to addressing global health challenges.

Products and Services

  • Cosmetic Skin Lightener
  • This offering involves the development of safe and effective skin lightening ingredients designed for the cosmetic industry. These products are tailored to meet the growing demand for skin care solutions that can help in achieving a more balanced and radiant skin tone, leveraging scientifically-backed formulations to ensure both efficacy and safety for users.

  • Diabetes Drug
  • Sirona Biochem is involved in the discovery and development of novel therapeutic agents aimed at managing diabetes. This initiative reflects the company’s dedication to addressing the global diabetes epidemic through innovation, by focusing on creating drugs that can offer improved outcomes for patients living with this challenging condition.

  • Anti-Aging/Cell Protection Library
  • The development of an anti-aging and cell protection library signifies Sirona Biochem's engagement in creating a comprehensive range of compounds designed to combat the signs of aging and protect the skin at the cellular level. This project aims at offering revolutionary products that can slow down the aging process, ensuring healthier and younger-looking skin.

  • Novel Anti-Wrinkle Compound
  • This initiative focuses on the formulation of a unique compound targeting the reduction of wrinkles, signifying the company’s commitment to advancing skincare solutions. Through cutting-edge research, Sirona Biochem seeks to offer innovative products that address the needs of consumers aiming for a smoother and more youthful appearance.

  • Anti-Viral Program
  • In collaboration with the International Centre for Genetic Engineering and Biotechnology (ICGEB), Sirona Biochem is dedicated to the development of an antiviral library of compounds. This program highlights the company’s proactive approach in contributing to the global fight against viral diseases, showcasing its capability to innovate in the realm of therapeutic solutions.

Contact Information

Address: 595 Burrard Street
Phone: 604 641 4466